Improve Precision Medicine Timelines in Community Oncology Care

Most oncology strategies are shaped by evidence and infrastructure that is built and measured in academic centers. Yet most patients are treated in community oncology settings, where biopsy timing, tissue adequacy, turnaround time for molecular results, payer utilization management and social determinants of health (SDOH) can determine whether precision medicine is delivered consistently.

In this webinar, the featured speakers will translate community oncology realities into clinically grounded insights for life sciences leaders developing oncology therapeutics, diagnostics and evidence strategies.

Using case-based examples and published community data, the discussion will examine how community practices put “precision medicine basics” into action. This includes choosing the right test for the clinical question, such as tumour NGS panels vs focused assays, germline testing when hereditary risk is suspected and circulating tumour DNA [ctDNA]/liquid biopsy when tissue is limited or serial assessment is clinically useful. It will also cover how practices coordinate ordering and interpretation across multidisciplinary teams and ensure biomarker results lead to treatment action.

The session will also examine why SDOH should be treated not simply as background context but as measurable factors that shape outcomes, access and the feasibility of generating longitudinal evidence in community oncology.

Register for this webinar to learn how a community oncology test-to-treat playbook can strengthen biomarker testing, treatment action and evidence strategies at scale.

Speakers

Susan Duffy, President, Amplity Comms

As President of Amplity Comms, Susan leads the creative communications professionals in delivering medical communications, media and strategic marketing solutions to help patients get on and stay on the right therapies. Susan comes to Amplity with 25 + years of biopharma marketing expertise spanning a variety of life sciences companies, channels and therapeutic areas. Susan has supported brands in mature and competitive markets, as well as brands that have defined and established new categories and standards of care. In oncology, she has worked with the Levine Cancer Institute, ASCO and helped launch several noteworthy oncology brands.

Message Presenter

Kristin Siyahian, VP of Branded Channels, Amplity

Kristin is a Communications Leader and Content Strategist serving healthcare communities. For more than 20 years, she has concentrated on connecting multidisciplinary oncology teams and patients to critical, timely information to help improve outcomes through multimedia platforms that leverage key clinical, lifestyle, access and business information. At Amplity, she leads communications and content strategy across the company’s medical communications oncology portfolio, directing the strategy and content for five additional platforms and overseeing the editorial launch of In Practice.

Message Presenter

Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates

Dr. Patel is a practicing Medical Oncologist and is board-certified in Hematology, Oncology and Internal Medicine. He is the immediate past President of the Community Oncology Alliance (COA) and has held leadership roles with the Association of Community Cancer Centers (ACCC). Dr. Patel has authored and presented more than 130 publications and is frequently quoted in national media on issues including COVID-19, health disparities and value-based care. He also serves as an Associate Professor of Medicine and advises payers and public-sector stakeholders on oncology policy, economics and care delivery, including value-based care initiatives and Oncology Care Model pilots.

Message Presenter